Interference of selected clinical medicines on DRI® and TDx® immunoassays of morphine and methamphetamine in urine

S. G. Chang, C. S. Chien, H. M. Lee, C. Y. Chen

研究成果: 雜誌貢獻文章

3 引文 斯高帕斯(Scopus)

摘要

Eleven commonly used antihistamines, nonsteroidal anti-inflammatory drugs, and vitamins were evaluated in vitro for potential interference with DRI® and TDx® immunoassay reagents for opiates and amphetamines. Mechanisms for the observed interference were also explored. DRI® reagents appear to be more susceptible to interference by the compounds studied. Regarding mechanistic aspects, tolmetin was found to be strongly absorbent at the detection wavelength (340 nm) causing a false negative response; diphenhydramine, pheniramine, and trimethobenzamide appeared to cause false positive interference through their affinity to the antibodies used in the DRI® reagents; while chlorpromazine was found to positively interfere with the assay through both cross reaction and UV absorption. Ascorbic acid, when in high concentrations (>2%, w/v), may inhibit the enzyme (G6PDH) activity and result in a false negative response.
原文英語
頁(從 - 到)259-268
頁數10
期刊Journal of Food and Drug Analysis
7
發行號4
出版狀態已發佈 - 1999

ASJC Scopus subject areas

  • Food Science
  • Pharmacology

指紋 深入研究「Interference of selected clinical medicines on DRI® and TDx® immunoassays of morphine and methamphetamine in urine」主題。共同形成了獨特的指紋。

  • 引用此